Need help? Talk to our expert.
WhatsApp


Research studies

At the heart of our diagnostic excellence is a commitment to research and innovation that drives meaningful advances in patient care. We continuously explore emerging technologies, refine testing methodologies, and contribute to scientific knowledge through evidence-based studies. By integrating robust research with cutting-edge innovation, we deliver diagnostics that are more accurate, more insightful, and more responsive to the evolving needs of clinicians and patients.

Publications

Research Studies

Search

Correlation of Presumptive Positive using TMS with Next generation sequencing (NGS) for Inborn Errors of Metabolism: a pilot clinical study for Indian newborn population.

Inborn errors of metabolism are rare inherited disorders which leads to significant morbidity and mortality in patients. Very few studies have been conducted in India to assess prevalence of Inborn Er...

NBS IEM TMS TR-FIA Prevalence NGS
Mentors: Dr. Alap Christy & Dr. Kirti Chadha
Published: Aug 2026

Determination of the clinical relevance of NIPS for the detection of fetal aneuploidies using NGS and understanding factors affecting the fetal fraction

Prenatal screening with maternal biochemical dual and quadruple markers, along with reflex testing using karyotyping, and non-invasive prenatal testing via next-generation sequencing (NIPT-NGS) were e...

NIPT Dual marker PregascreenTM
Mentors: Dr Monisha Banerjee, Dr. Aparna Rajadhyaksha & Dr. Kirti Chadha
Published: Aug 2026

Comparative analysis of thinprep and cell solution liquid based cervical cytology with hpv testing: a study of 412 cases

Cervical cancer remains a major health burden, particularly in developing countries, where inadequate screening contributes substantially to mortality. LBC improves smear quality and allows the residu...

Liquid-based cytology Cervical cancer ThinPrep CellSolutions HPV
Mentors: Dr Shaikhali Barodawala
Published: Aug 2026

Analysis of mutation spectrum in hboc cohort specifically brca 1/2 of Indian population

 The objective of this study was to determine the prevalence and spectrum of genetic mutations linked to inherited breast and ovary cancer (HBOC) in the Indian population, and to evaluate the cor...

NGS breast cancer ovarian cancer
Mentors: Dr Kunjal Lila
Published: Sep 2026

Analysis, morphological characterization, immunohistochemistry and fluorescence in-situ hybridization of Adult and Paediatric Indian Soft Tissue Sarcoma population

This study evaluated the spectrum and diagnostic characteristics of malignant soft tissue sarcomas in the Indian population through a retrospective analysis of 25,109 soft tissue cases, including 1,21...

Soft tissue sarcoma; Immunohistochemistry; FISH; Sarcoma diagnosis
Mentors: Dr Shaikhali Barodawala
Published: Sep 2026

About Us

Metropolis Healthcare is one of India’s leading diagnostics companies, with 45 years of experience built on scientific expertise, quality and trust. We serve millions of patients through a growing network supported by advanced laboratory infrastructure, technology and a patient-first approach. Our comprehensive portfolio includes 4,500+ tests and profiles across routine, specialised and super-specialised diagnostics, spanning pathology, molecular diagnostics, genomics, cytogenetics, oncology, neurology, nephrology, women and child health, preventive healthcare and wellness.

With 210+ clinical laboratories and a service network of 5,000+ touchpoints reaching more than 750 towns in India, we are focused on making trusted diagnostic services more accessible while maintaining rigorous quality standards. By combining scientific excellence, advanced technology and human expertise, we deliver accurate, reliable and relevant diagnostic insights that support better-informed healthcare decisions.

Proceed

To book your home visit call us at 080-4891-1400

Book a Home Visit Now!

080-4891-1400